- Industry on tenterhooks over Indian trial compensation
- 5 burning questions for India's crisis-hit clinical research community
- Is the Indian clinical trials segment pick up a mirage?
- Experts slam crippling Indian trial regulations
ANALYSIS Other Informa Analysis
COMMENT Other Informa Comment
- Scrip 100: Chugai USA's new CMO is a Man for All Regions
- Profile: Janssen R&D boss on the next big thing in medicine & 'ice bucket' funding